Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Other financing activities: 2021-2025

Historic Other financing activities for MDxHealth (MDXH) over the last 4 years, with Sep 2025 value amounting to -$2.6 million.

  • MDxHealth's Other financing activities fell 30.33% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.1 million, marking a year-over-year decrease of 179.07%. This contributed to the annual value of -$6.7 million for FY2024, which is 285.65% down from last year.
  • As of Q3 2025, MDxHealth's Other financing activities stood at -$2.6 million, which was down 1.00% from -$2.6 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Other financing activities registered a high of -$240,000 during Q1 2022, and its lowest value of -$2.6 million during Q3 2025.
  • In the last 2 years, MDxHealth's Other financing activities had a median value of -$2.0 million in 2024 and averaged -$2.2 million.
  • Its Other financing activities has fluctuated over the past 5 years, first rose by 0.78% in 2022, then plummeted by 30.33% in 2025.
  • MRQ analysis of 4 years shows MDxHealth's Other financing activities stood at -$767,000 in 2021, then skyrocketed by 33.38% to -$511,000 in 2022, then tumbled by 252.84% to -$1.8 million in 2024, then crashed by 45.37% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q3 2025, -$2.6 million for Q2 2025, and -$2.0 million during Q1 2025.